Stereotaxis Inc (STXS) – Company Profile and SWOT Analysis

Stereotaxis Inc (STXS) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Stereotaxis Inc (Stereotaxis) designs, manufactures, and markets robotic systems, instruments and information solutions to improve the treatment of arrhythmias and coronary artery disease. The company's major products include the Odyssey Solution, the Niobe System, Genesis RMN System, Stereotaxis imaging model S x-ray system and related devices. It also offers maintenance and support services for its integrated products directly and also through third-party service representatives. The company markets products through a direct sales force and through distributors and sales agents in the US, Europe, and other parts of the world. Stereotaxis is headquartered in St. Louis, Missouri, the US.

Scope

• Detailed information on Stereotaxis Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Stereotaxis Inc in the form of a SWOT analysis

• An in-depth view of the business model of Stereotaxis Inc including a breakdown and examination of key business segments

• News about Stereotaxis Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Stereotaxis Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Stereotaxis Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Stereotaxis Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

VytronUS Inc

Microbot Medical Inc

CardioFocus Inc

Iowa Approach Inc.

CyberHeart Inc

Corindus Vascular Robotics Inc

Intuitive Surgical Inc

Baylis Medical Company Inc

Verb Surgical Inc

BioSig Technologies Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Stereotaxis Inc - Key Facts

Stereotaxis Inc - Key Employees

Stereotaxis Inc - Key Employee Biographies

Stereotaxis Inc - Major Products and Services

Stereotaxis Inc - History

Stereotaxis Inc - Company Statement

Stereotaxis Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Stereotaxis Inc - Business Description

Product Category: Disposables, Service and Accessories

Performance

Product Category: Systems

Performance

Geographical Segment: International

Performance

Geographical Segment: The US

Performance

R&D Overview

Stereotaxis Inc - Corporate Strategy

Stereotaxis Inc - SWOT Analysis

SWOT Analysis - Overview

Stereotaxis Inc - Strengths

Stereotaxis Inc - Weaknesses

Stereotaxis Inc - Opportunities

Stereotaxis Inc - Threats

Stereotaxis Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Stereotaxis Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024

Stereotaxis Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024

Stereotaxis Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Sep 03, 2024: Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress

Aug 12, 2024: Stereotaxis Reports 2024 Second Quarter Financial Results

Jul 18, 2024: Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir

May 24, 2024: Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework

May 15, 2024: Stereotaxis Invited By Africa Heart Rhythm Association To Present Its Innovative Robotic Solution To Expand High-quality Therapy In Underserved Regions Of Africa

May 13, 2024: Stereotaxis Reports 2024 First Quarter Financial Results

Mar 04, 2024: Stereotaxis Reports 2023 Full Year Financial Results

Oct 04, 2023: Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation

Aug 16, 2023: Inaugural Science Olympiad Alumni Research (Soar) Grant Recipients Cedlive Long-distance Telerobotic Procedures To Highlight Stereotaxis Technology At Asia Pacific Heart Rhythm Symposium

May 09, 2023: Stereotaxis Reports 2023 First Quarter Financial Results

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Stereotaxis Inc, Key Facts

Stereotaxis Inc, Key Employees

Stereotaxis Inc, Key Employee Biographies

Stereotaxis Inc, Major Products and Services

Stereotaxis Inc, History

Stereotaxis Inc, Other Locations

Stereotaxis Inc, Subsidiaries

Stereotaxis Inc, Key Competitors

Stereotaxis Inc, Ratios based on current share price

Stereotaxis Inc, Annual Ratios

Stereotaxis Inc, Annual Ratios (Cont…1)

Stereotaxis Inc, Annual Ratios (Cont…2)

Stereotaxis Inc, Interim Ratios

Stereotaxis Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024

Stereotaxis Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024

Stereotaxis Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Stereotaxis Inc, Performance Chart (2019 – 2023)

Stereotaxis Inc, Ratio Charts

Stereotaxis Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024

Stereotaxis Inc, Medical Equipment, Deals by Type, 2018 to YTD 2024

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports